RTI Biologics Announces Distribution and Supply Agreement with Aesculap for Biocleanse(R)-Sterilized Spinal Allografts

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics, Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, announced today that it has signed an agreement to provide spinal allograft implants to Aesculap Implant Systems, Inc.

Back to news